Starting Mounjaro? Learn the common side effects you may experience week by week, how long they last, practical tips to reduce nausea and digestive symptoms, and when to seek medical advice.

Retatrutide is an investigational triple receptor agonist that targets GLP-1, GIP, and glucagon receptors for weight management and metabolic health. Learn how it works, the latest research, and why it is not yet approved in Malaysia.

Dieting alone may not be enough for sustainable weight loss. In Malaysia, medical weight loss treatments are becoming increasingly popular for targeting stubborn fat and metabolic issues. Learn the differences, benefits, and which option is right for you.

Mounjaro (Tirzepatide GLP-1 Agonist) is the latest innovative dual-action injectable treatment primarily used for treating type 2 diabetes and has also shown strong secondary effectiveness in weight loss.

The rising rates of obesity in Malaysia present a significant public health challenge. With obesity affecting a large segment of the population, it’s vital to explore the statistics, risk factors, and potential treatments to effectively tackle this issue. This post will examine the weight loss landscape in Malaysia, shedding light on key statistics, causal factors behind weight gain, and available treatments for those striving to lose weight. Weight Loss Statistics for the Ma